Skip to main content

More on Pirfenidone in Japan

The following article appeared on PharmaLive.com. I thought those of us with Hermansky-Pudlak Syndrome might be interested. I'm excited about it. To me, it just bolsters the case that Pirfenidone could be useful to us. And, hopefully, the research in Japan will only help us here as well.

Shionogi: Results of Phase III Clinical Trials of the Idiopathic Pulmonary Fibrosis Treatment S-7701

OSAKA, December 22, 2006 — Shionogi & Co., Ltd. (Head Office: Osaka; President: Motozo Shiono) today announced that it has achieved the primary objectives of Phase III clinical trials for the idiopathic pulmonary fibrosis treatment S-7701 (generic name: pirfenidone), which the Company is developing in Japan under a license from U.S.-based Marnac, Inc. and KDL, Inc., Tokyo.

Idiopathic pulmonary fibrosis (IPF) is a medical condition of unknown etiology with poor prognosis in which progressive fibrosis of the alveolar walls produces irreversible “honeycomb lung”*. In general, restrictive impairment (reduction of vital capacity (VC) and total lung capacity (TLC)) is evident. As the symptom (fibrosis of the alveolar walls) progresses, gas exchange in the lungs (exchange of oxygen and carbon dioxide) becomes difficult. In some cases, oxygen therapy becomes necessary. Because of its severity, IPF is designated as a “specified disease” (in other words, an intractable disorder).

Under development as a treatment for IPF, S-7701 has been designated as an orphan drug (a drug used to treat a rare disease) by the Pharmaceuticals and Medical Devices Agency.

Honeycomb lung: A high-resolution CT scan of the lung yields a honeycomb pattern. In the Phase III clinical trials for this drug with VC change (from before commencement of treatment to 52 weeks after commencing treatment) as the primary endpoint, both high and low doses of the drug (600mgl per day, three times a day and 400mgl per day, three times a day, respectively), significantly inhibited worsening of the condition compared with a placebo.

While continuing to conduct further analysis and study, Shionogi plans to expedite the application process based on these clinical results, with the intention of submitting a new drug application (NDA) within the current fiscal year.

In the process of developing this drug, Shionogi has received many earnest inquiries from patients with IPF and their families regarding the extent of progress of development, and urgent requests for the medication. With this situation in mind, Shionogi intends to do its best to expedite submission and approval for S-7701 in order to offer the quickest possible relief to patients suffering from this disease.

For further information, contact:Public Relations UnitShionogi & Co., Ltd.(Osaka)Tel: +81-6-6209-7885 Fax: +81-6-6229-9596(Tokyo)Tel: +81-3-3406-8164 Fax: +81-3-3406-8099.

Comments

Anonymous said…
Hi Heather:
Thanks for posting this. I found it very interesting. Yesterday, I got a booklet from my insurance company entitled How to Manage Your COPD. I realized that my doctor must be putting COPD as my diagnosis in the forms they submit to the insurance company. Since HPS is so rare they do this to simplify things, as COPD is more common. Should I do anything about this? Is COPD a good generalization?
Okay, take this with a grain of salt. I'm not a doc you know. Grin!

I've got a friend who is the same age as I am and has COPD because of lupus. Actually, she has much more severe breathing problems than I do and is caring for three children under the age of seven. Makes me shiver!

Anyway, although our lung problems are not caused by the same thing, we find we have a lot of the same practical problems and can benefit from some of the same coping strategies. So, hey, read up on COPD and let me know if you find anything helpful!

But, COPD and pulmonary fibrosis, as I understood, are not the same thing. If you think your doc. is writing COPD in your chart and you think your problems are really fibrosis, might be worth a conversation to find out why. Yes, HPS probably isn't on their list of codes, sort of speak. But pulmonary fibrosis should be.

When I was at ATS (American Thoracic Society) I went to the symposium on COPD. The causes weren't the same, but I still could very much relate to some of the common symptoms they talked about.
Unknown said…
Chronic obstructive pulmonary disease is a lung disease in which the lung is damaged, making it hard to breathe.COPD is more common. Should I do anything about this.
COPD patients should not do hard work Anyway, although our lung problems are not caused by the same thing.What is the prevention of this desease.

George Kevin
Connecticut Drug Treatment
Anonymous said…
Gentlemen ;
Can I get Pirfenidone from you here in the STATES
Name: Dr. M. Rashed.
e. mail: moustafa.rashed@yahoo.com
Phone # (U.S.A.): (954-392-8392

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Help for one of our newest HPS friends

As many of you know, I have a google alert set up for all sorts of key terms like albinism, pulmonary fibrosis etc. The following was posted on the blog of a friend of Melanie's. Melanie is one of our newest members of the Hermansky-Pudlak Syndrome family. Unfortunately, like so many she didn't know she had HPS and the lung disease sort of snuck up on her. Melanie will be 26 years old next week. Perhaps some of us would like to contribute to the fund set up to help her and her family for her birthday. Here's the post: Melanie Hernandez, beloved sister and daughter to Pete, Monique, Cookie, and Bugie, has been diagnosed with Pulmonary Fibrosis, a lung disease occurring in people with Hermansky-Pudlak Syndrome, a very rare disease.Hermansky-Pudlak Syndrome (“HPS”) is a genetic metabolic disorder. It is characterized by: Albinism, Vision Impairment, Bleeding Disorder, Inflammatory Bowel Disease and Lung Disease – Pulmonary Fibrosis. With the family’s research and the recollect